- About Lung Cancer
- Support & Resources
- Make a Difference
Friday, July 30, 2010--Yesterday, the full Senate Appropriations Committee approved the package of research funding increases approved earlier this week by the Subcommittee on Labor, Health and Human Services, Education and Related Agencies. This approval adds $1 billion in funding to the National Institutes of Health (NIH) for the coming fiscal year, beginning October 1, for a total of $32 billion. There is a possibility that an additional $1 or $2 billion will be added by the Committee on on the Senate floor. The House appropriations subcommittee of jurisdiction approved $32 billion for NIH on July 15.
Under the Senate version the allocation for the National Cancer Institute (NCI), the largest under NIH , would be increased to $5,256,409,000.
LCA strongly supported even higher increases for NIH said LCA President and CEO Laurie Fenton-Ambrose. "We have consistently supported increases in research funding but we still have not seen any meaningful increase in lung cancer research funding or any coherent plan of attack for the leading cancer killer. Hopefully with the new leadership of Dr. Francis Collins at NIH and Dr. Harold Varmus at NCI
reducing lung cancer mortality will finally become a priority."